Key result
This review provides a framework for shared decision-making regarding the benefits, risks, and use of implantable cardioverter-defibrillators and cardiac resynchronization therapy in older adults.
Why the study?
Competing mortality risks, comorbid conditions, and frailty complicate evaluating the risk-benefit trade-offs of ICDs and CRT in older adults with heart failure.
This review discusses the benefits, risks, and use of ICD and CRT in older adults with heart failure, introducing a framework for shared decision-making.
No takes yet. Share an insight, caveat, or question.
May aid shared decision-making for ICD/CRT in older adults; leaves open prospective validation of the framework.
Sandhu et al. (2019) conducted a review in Heart failure. Implantable cardioverter-defibrillators (ICDs) and cardiac resynchronization therapy (CRT) was evaluated. This review provides a framework for shared decision-making regarding the benefits, risks, and use of implantable cardioverter-defibrillators and cardiac resynchronization therapy in older adults.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: